Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer

被引：9
作者：
Coster, Jenalee N. [1 ]
Groth, Shawn S. [1 ]
机构：
[1] Baylor Coll Med, Micheal E DeBakey Dept Surg, Div Thorac Surg, 7200 Cambridge St,Ste 6A, Houston, TX 77030 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2020年 / 29卷 / 04期
关键词：
Non-small cell lung carcinoma; Locally advanced non-small cell lung cancer; Chest wall invasion; Superior sulcus tumors; Salvage surgery; Stage IIIA N2; Definitive chemoradiation; Oligometastatic lung cancer; ISOLATED ADRENAL METASTASIS; SURGICAL RESECTION; SALVAGE SURGERY; CHEST-WALL; SURVIVAL; STAGE; CHEMOTHERAPY; MANAGEMENT; THERAPY; CHEMORADIOTHERAPY;
D O I：
10.1016/j.soc.2020.07.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Locally advanced NSCLC is a complex, heterogeneous disease process that requires a thoughtful, multidisciplinary approach. In highly select patients with an excellent performance status and the absence of N2 disease, surgical resection of locally advanced and limited oligometastatic NSCLC offers a survival benefit when combined with a multimodal treatment strategy. With advancements in and the increasing application of immunotherapy, the multidisciplinary perspective of locally advanced NSCLC will continue to evolve.
引用
收藏
页码：543 / 554
页数：12
相关论文
共 47 条
  • [1] AJCC, 2016, AJCC CANC STAG MAN L
  • [2] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
    Albain, Kathy S.
    Swann, R. Suzanne
    Rusch, Valerie W.
    Turrisi, Andrew T., III
    Shepherd, Frances A.
    Smith, Colum
    Chen, Yuhchyau
    Livingston, Robert B.
    Feins, Richard H.
    Gandara, David R.
    Fry, Willard A.
    Darling, Gail
    Johnson, David H.
    Green, Mark R.
    Miller, Robert C.
    Ley, Joanne
    Sause, Willliam T.
    Cox, James D.
    [J]. LANCET, 2009, 374 (9687) : 379 - 386
  • [3] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    Andrews, DW
    Scott, CB
    Sperduto, PW
    Flanders, AE
    Gaspar, LE
    Schell, MC
    Werner-Wasik, M
    Demas, W
    Ryu, J
    Bahary, JP
    Souhami, L
    Rotman, M
    Mehta, MP
    Curran, WJ
    [J]. LANCET, 2004, 363 (9422) : 1665 - 1672
  • [4] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Kurata, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    Carpeno, J. de Castro
    Faivre-Finn, C.
    Reck, M.
    Vansteenkiste, J.
    Spigel, D. R.
    Wadsworth, C.
    Melillo, G.
    Taboada, M.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) : 2342 - 2350
  • [5] Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes
    Bauman, Julie E.
    Mulligan, Michael S.
    Martins, Renato G.
    Kurland, Brenda F.
    Eaton, Keith D.
    Wood, Douglas E.
    [J]. ANNALS OF THORACIC SURGERY, 2008, 86 (05) : 1632 - 1639
  • [6] Surgical treatment of primary lung cancer with synchronous brain metastases
    Billing, PS
    Miller, DL
    Allen, MS
    Deschamps, C
    Trastek, VF
    Pairolero, PC
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (03) : 548 - 553
  • [7] Blasberg JD, 2020, SUGARBAKERS ADULT CH, P755
  • [8] Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option
    Bograd, Adam J.
    Mann, Catherine
    Gorden, Jed A.
    Gilbert, Christopher R.
    Farivar, Alex S.
    Aye, Ralph W.
    Louie, Brian E.
    Vallieres, Eric
    [J]. ANNALS OF THORACIC SURGERY, 2020, 110 (04) : 1123 - 1130
  • [9] Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer
    Bott, Matthew J.
    Yang, Stephen C.
    Park, Bernard J.
    Adusumilli, Prasad S.
    Rusch, Valerie W.
    Isbell, James M.
    Downey, Robert J.
    Brahmer, Julie R.
    Battafarano, Richard
    Bush, Errol
    Chaft, Jamie
    Forde, Patrick M.
    Jones, David R.
    Broderick, Stephen R.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (01) : 269 - 275
  • [10] Does induction chemoradiotherapy increase survival in patients with Pancoast tumour?
    Buderi, Silviu I.
    Shackcloth, Michael
    Woolley, Steven
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2016, 23 (05) : 821 - 825
12345